SLC22A17 and Anxiety: The genetic knockdown manipulation of SLC22A17 in mPFC effectively attenuated LCN2-mediated anxiety-like behaviors (Fig. S4a–h), whilst the receptor ablation in hippocampus or BLA did not prevented the LCN2 effect (Fig. S4i–x).